Per Share Information

6 Months Ended

Mar. 31, 2019

5. PER SHARE INFORMATION

The following tables reconcile the components of basic and diluted earnings per share for the three and six months ended March 31, 2019, and 2018:

	Three Months Ended March 31,
	2019		2018
Numerator:
Net income attributable to common stockholders of IES Holdings, Inc.	$	5,467	$	2,250
Decrease in noncontrolling interest		-		(44)
Net income attributable to restricted stockholders of IES Holdings, Inc.		22		15
Net income attributable to IES Holdings, Inc.	$	5,489	$	2,221

Denominator:
Weighted average common shares outstanding — basic		21,139,096		21,182,268
Effect of dilutive stock options and non-vested restricted stock		240,650		258,302
Weighted average common and common equivalent shares outstanding — diluted		21,379,746		21,440,570

Earnings per share attributable to IES Holdings, Inc.:
Basic	$	0.26	$	0.11
Diluted	$	0.26	$	0.11

	Six Months Ended March 31,
	2019		2018
Numerator:
Net income (loss) attributable to common stockholders of IES Holdings, Inc.	$	12,348	$	(27,304)
Decrease in noncontrolling interest		-		(44)
Net income (loss) attributable to restricted stockholders of IES Holdings, Inc.		25		-
Net income (loss) attributable to IES Holdings, Inc.	$	12,373	$	(27,348)

Denominator:
Weighted average common shares outstanding — basic		21,187,834		21,189,641
Effect of dilutive stock options and non-vested restricted stock		236,688		-
Weighted average common and common equivalent shares outstanding — diluted		21,424,522		21,189,641

Earnings (loss) per share attributable to IES Holdings, Inc.:
Basic	$	0.58	$	(1.29)
Diluted	$	0.58	$	(1.29)

When an entity has a net loss, it is prohibited from including potential common shares in the computation of diluted per share amounts. Accordingly, we have utilized basic shares outstanding to calculate both basic and diluted loss per share for the six months ended March 31, 2018. The number of potential anti-dilutive shares excluded from the calculation was 255,146 shares. For the three months ended March 31, 2018, and the three and six months ended March 31, 2019, the average price of our common shares exceeded the exercise price of all of our outstanding options; therefore, all of our outstanding stock options were included in the computation of fully diluted earnings per share.